← Leaderboards
Claudio A.p. Joazeiro
American Association For Cancer Research
$7,520,796
Attributed
$11,013,977
Total exposure
8
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $993.9K · FY2006–25$1M$750K$500K$250K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$11,013,977 · 8
By mechanism
R01$10,957,352 · 4
P41$38,625 · 2
R13$18,000 · 2
Top collaborators
- Gregory A Cox9 shared
- Robert W Burgess3 shared
Others in their field
Top investigators on “Proteins”
- David Heimbrook · Leidos Biomedical Research, Inc.$354,061,551
- Randall J Bateman · Washington University$187,292,085
- Paul S. Aisen · Cognition Therapeutics, Inc.$175,382,342
- Reisa A. Sperling · Banner Health$145,046,481
- Barton F Haynes · Duke University$136,029,850
- Joseph L Goldstein · University Of Texas Sw Med Ctr/Dallas$102,433,280
Research focus
ProteinsUbiquitin-Protein LigaseMutationBiochemicalBaseMediatingGenesCellsPathway InteractionsExhibitsReportingPolypeptideLeadStructureUbiquitinPost-Translational Protein ProcessingUbiquitinationMolecularResponseQuality ControlNovel TherapeuticsModificationMolecular GeneticsPlay
Grant awards (27)
Polyalanine Tails: A Novel Type of Protein Modification Implicated in Neurodegeneration$735,524
R01 · FY2025 · NS
Polyalanine Tails: A Novel Type of Protein Modification Implicated in Neurodegeneration$717,158
R01 · FY2024 · NS
Polyalanine Tails: A Novel Type of Protein Modification Implicated in Neurodegeneration$732,174
R01 · FY2023 · NS
Polyalanine Tails: A Novel Type of Protein Modification Implicated in Neurodegeneration$751,212
R01 · FY2022 · NS
FASEB SRC: The Ubiquitin & Ub-like proteins Conference: Cell Functions and Therapeutic Targeting$13,000
R13 · FY2022 · CA · contact PI
CAT-tails: A Novel Type of Protein Modification Implicated in Neurodegeneration$662,384
R01 · FY2021 · NS
CAT-tails: A Novel Type of Protein Modification Implicated in Neurodegeneration$662,384
R01 · FY2020 · NS
CAT-tails: A Novel Type of Protein Modification Implicated in Neurodegeneration$659,497
R01 · FY2019 · NS
CAT-tails: A Novel Type of Protein Modification Implicated in Neurodegeneration$659,497
R01 · FY2018 · NS
CAT-tails: A Novel Type of Protein Modification Implicated in Neurodegeneration$678,247
R01 · FY2017 · NS
Small Molecule Inhibitors of Mdm2 E3 Ubiquitin Ligase Activity for Cancer Therapy$393,213
R01 · FY2016 · CA · contact PI
A New E3 Ligase Implicated in Protein Quality Control and Neurodegeneration$378,984
R01 · FY2016 · NS · contact PI
A New E3 Ligase Implicated in Protein Quality Control and Neurodegeneration$414,531
R01 · FY2015 · NS · contact PI
Small Molecule Inhibitors of Mdm2 E3 Ubiquitin Ligase Activity for Cancer Therapy$393,213
R01 · FY2015 · CA · contact PI
A New E3 Ligase Implicated in Protein Quality Control and Neurodegeneration$410,387
R01 · FY2014 · NS · contact PI
Small Molecule Inhibitors of Mdm2 E3 Ubiquitin Ligase Activity for Cancer Therapy$381,417
R01 · FY2014 · CA · contact PI
A New E3 Ligase Implicated in Protein Quality Control and Neurodegeneration$400,023
R01 · FY2013 · NS · contact PI
Small Molecule Inhibitors of Mdm2 E3 Ubiquitin Ligase Activity for Cancer Therapy$369,620
R01 · FY2013 · CA · contact PI
A New E3 Ligase Implicated in Protein Quality Control and Neurodegeneration$414,531
R01 · FY2012 · NS · contact PI
Small Molecule Inhibitors of Mdm2 E3 Ubiquitin Ligase Activity for Cancer Therapy$393,213
R01 · FY2012 · CA · contact PI
MODULATION OF NF-kB ACTIVATION BY A NOVEL MITOCHONDRIAL E3 UBIQUITIN LIGASE$186,121
R01 · FY2012 · GM · contact PI
MODULATION OF NF-kB ACTIVATION BY A NOVEL MITOCHONDRIAL E3 UBIQUITIN LIGASE$186,121
R01 · FY2011 · GM · contact PI
STRUCTURE OF AN E3 LIGASE COMPLEX$25,707
P41 · FY2011 · RR · contact PI
MODULATION OF NF-kB ACTIVATION BY A NOVEL MITOCHONDRIAL E3 UBIQUITIN LIGASE$188,001
R01 · FY2010 · GM · contact PI
STRUCTURE OF AN E3 LIGASE COMPLEX$12,918
P41 · FY2010 · RR · contact PI
MODULATION OF NF-kB ACTIVATION BY A NOVEL MITOCHONDRIAL E3 UBIQUITIN LIGASE$189,900
R01 · FY2009 · GM · contact PI
Ubiquitin/Cancer:Molecular Targets/Mechanisms to Clinic$5,000
R13 · FY2006 · CA · contact PI